19 results · 30ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ATTAIN CLARITY 6225 VENOGRAM BALLOON CATHETER

FDA 510(k)
FDA Class 2 ·Cardiovascular

Integra® Jarit®

FDA UDI
INTEGRA LIFESCIENCES PRODUCTION CORPORATION·10381780180272·Integra® Jarit® Cooley Intracardiac Needle Hold...

Punch

FDA UDI
ELLIQUENCE, LLC·00846338004187·

BELIFU

FDA Adverse Event
Injury ·HONG QIANGXING (SHEN ZHEN) ELECTRONICS LIMITED·Product code GZJ·February 10, 2020

UniTip High Resolution Catheter

FDA UDI
Unisensor AG·07640172970423·

UniTip High Resolution Catheter

FDA UDI
Unisensor AG·07640172970393·

UniTip High Resolution Catheter

FDA UDI
Unisensor AG·07640172970416·

UniTip High Resolution Catheter

FDA UDI
Unisensor AG·07640172970409·

GMD UNIVERSAL URINARY INCONTINENCE SLING

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

SMARTWIRE/SMARTMAP PRESSURE SYSTEM

FDA 510(k)
FDA Class 2 ·Cardiovascular

SYSTEM 6 SAGITTAL SAW

FDA Adverse Event
Malfunction ·STRYKER INSTRUMENTS-KALAMAZOO·Product code KIJ·May 20, 2013

POWERED WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code ITI·September 26, 2014

UNKNOWN DEPUY TIBIAL INSERT

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS, INC.·Product code JWH·June 1, 2011

BD FACSCALIBUR¿

FDA Adverse Event
Malfunction ·BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES·Product code GKZ·December 28, 2021

ACCESS ACCUTNI REAGENT

FDA Adverse Event
Injury ·BECKMAN COULTER·Product code MMI·September 15, 2016

Eversense CGM SENSOR (FG-4200-00-301)-Continuous Glucose Monitor

FDA Enforcement
Class II ·Terminated·Senseonics, Inc.·November 6, 2019

Various products which were contract sterilized.

FDA Enforcement
Class II ·Ongoing·Anewmed Corporation·November 6, 2019

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024

Alcon Custom Pak

FDA Enforcement
Class II ·Ongoing·Alcon Research, LTD.·August 23, 2023